Itedale Namro holds a PhD degree in Chemistry with emphasis on Medicinal/Organic Chemistry from the University of Gothenburg. Her doctoral work focused on the synthesis and evaluation of drugs for deriving treatment against orphaned diseases. She obtained her Postdoctoral training in Chemical Biology at the Gladstone Institutes in San Francisco where she was part of the team who pioneered the use of small molecules for manipulation of stem cell fate. After her postdoc, she was an Assistant Professor at the Clinical Chemistry and Transfusion Medicine at the University of Gothenburg where she was leading projects related to the use of small molecules for manipulation of stem cell fate in the fields of neural, cardiac and cartilage research. She joined CELLINK in 2018 as the Chief Scientific Officer, leading the Scientific and Applications team, developing high quality and well-designed bioink related products that was offered to the 3D-bioprinting community. Today, Itedale is the Head of Strategic Partnerships at Anyo Labs. At Anyo Labs, our cutting-edge AI technology is revolutionizing drug development, transforming it into a precise engineering discipline. By leveraging advanced models and logical decision-making, Anyo Labs aim to create life-saving treatments tailored to individual needs.